Subodh Verma

MD, PhD, FRCSC, FAHA

Scientist

Biography

Please note: Dr. Verma will not take students in summer.

Dr. Subodh Verma is an internationally renowned cardiac surgeon-scientist and Professor at the University of Toronto. He is the current Canada Research Chair in Cardiovascular Surgery, having previously served as the Canada Research Chair in Atherosclerosis (2007-2017). Dr. Verma was recently awarded the 2021 Lister Prize in Surgery from the University of Toronto in recognition of his outstanding and continuing productivity of international stature. He is a past recipient of the Howard Morgan Award for Distinguished Achievements in Cardiovascular Research and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is an appointee of the American Association of Thoracic Surgeons (AATS) and a member of the College of New Scholars, Artists and Scientists, Royal Society of Canada. According to Google Scholar in April 2021, Dr. Verma has an h-index of 100 and his work has been cited over 50,000 times.

Dr. Verma has published extensively in highly impactful journals like the NEJM, Lancet, Circulation, JACC, Nature, and JCI. He is an Associate Editor of the European Heart Journal. Dr. Verma is an active contributor to Canadian clinical practice guidelines and co-authored the recently updated recommendations for atrial fibrillation, antiplatelet therapy, diabetes, and heart failure; he was a member of the 2018 AATS consensus guidelines committee on bicuspid aortic valve-related aortopathy. Dr. Verma has served in various capacities on the American Heart Association Council on Cardiovascular Surgery and Anesthesia since 2008.

Dr. Verma had/has leadership roles on 10 contemporary global heart failure trials – several of which have let to paradigm changes in how individuals all around the world who live with diabetes and heart failure are now managed. He founded and oversees the CardioLink platform at St Michael’s Hospital that is conducting cardiometabolic and surgically oriented RCTs and translational studies.

Dr. Verma leads a dynamic pre-clinical and translational research team that leverages pre-clinical disease models and clinical trial-derived data to identify novel mediators of cardiovascular and cardiometabolic disease as well as answer timely and relevant healthcare questions. His research has yielded 2 United States patents and is supported by several national peer-reviewed grants.

 

Recent Publications

  1. Dhingra, NK, Verma, R, Mazer, CD, Verma, S. Generalizability of SELECT to Cardiac Surgical Patients: Analysis of the TRICS III Randomized Trial. JACC Adv. 2025;4 (3):101597. doi: 10.1016/j.jacadv.2025.101597. PubMed PMID:39954345 .
  2. Van Linthout, S, Spillmann, F, Verma, S. Empagliflozin's anti-inflammatory spectrum in type 2 diabetes mellitus: Piecing together the puzzle. Eur J Heart Fail. 2025; :. doi: 10.1002/ejhf.3604. PubMed PMID:39939875 .
  3. Patel, SK, Badross, MS, Dhingra, NK, Moroney, M, Casey, JH, Ali Hassan, SM et al.. Emerging Implications of Elevated Lipoprotein(a) Levels in Coronary Artery Bypass Graft Surgery: A Narrative Review. Ann Thorac Surg. 2025; :. doi: 10.1016/j.athoracsur.2025.01.013. PubMed PMID:39889843 .
  4. Houlden, RL, Gilbert, JD, Khan, TS, Mazer, CD, Trinacty, J, Verma, S et al.. Perioperative and Periprocedural Management of Once-Weekly Insulin Treated Patients. Endocr Pract. 2025; :. doi: 10.1016/j.eprac.2025.01.009. PubMed PMID:39884510 .
  5. Goldenberg, RM, Gilbert, JD, Houlden, RL, Khan, TS, Makhija, S, Mazer, CD et al.. Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms. Curr Med Res Opin. 2025; :1-17. doi: 10.1080/03007995.2025.2458538. PubMed PMID:39871617 .
  6. Mazer, CD, Moody, AR, Teoh, H, Quan, A, Elituv, R, Vivekanandan, T et al.. SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis. Circulation. 2025;151 (4):351-355. doi: 10.1161/CIRCULATIONAHA.124.072285. PubMed PMID:39869672 .
  7. An, KR, Sandner, S, Peper, J, Zhou, Y, Ten Berg, JM, Harik, L et al.. Association between white blood cell count and coronary artery bypass graft failure: an individual patient data analysis of clinical trials. J Cardiothorac Surg. 2025;20 (1):90. doi: 10.1186/s13019-024-03330-5. PubMed PMID:39849567 PubMed Central PMC11756219.
  8. Davies, MJ, van der Meer, P, Verma, S, Patel, S, Chinnakondepalli, KM, Borlaug, BA et al.. Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2025; :. doi: 10.1016/S2213-8587(24)00304-8. PubMed PMID:39848268 .
  9. Hibino, M, Ueyama, HA, Halkos, ME, Grubb, KJ, Verma, R, Majeed, A et al.. Valvular Heart Disease-Related Mortality Between Middle- and High-Income Countries During 2000 to 2019. JACC Adv. 2024;3 (12):101133. doi: 10.1016/j.jacadv.2024.101133. PubMed PMID:39817085 PubMed Central PMC11733992.
  10. Verma, S, Mori, M, Gaudino, M. Preoperative Telerehabilitation Improves Outcomes After Cardiac Surgery. J Am Coll Cardiol. 2024; :. doi: 10.1016/j.jacc.2024.11.031. PubMed PMID:39772359 .
Search PubMed

Affiliations & Other Activities

  • Cardiac Surgeon, Division of Cardiology , St. Michael’s Hospital
  • Professor of Surgery and Pharmacology & Toxicology, University of Toronto
  • Canada Research Chair in Cardiovascular Surgery